Several studies have reported that PTK6 and c-erbB-2 protein expression in breast cancer is positively correlated, suggesting they play a synergistic role in the occurrence and development of breast cancer, and therefore it has been suggested that inhibition of both these signaling proteins may be more effective in the control of breast cancer [20, 50–53]. The gene discussed is PTK6; the disease is breast carcinoma.